The purpose of this study is to evaluate the safety, tolerability, drug levels, and preliminary efficacy of BMS-986507 combinations in adult participants with advanced solid tumors.
Lung Cancer
The purpose of this study is to evaluate the safety, tolerability, drug levels, and preliminary efficacy of BMS-986507 combinations in adult participants with advanced solid tumors.
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
-
Local Institution - 0009, Miami, Florida, United States, 33136
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States, 07601
Local Institution - 0029, Cleveland, Ohio, United States, 44195
Local Institution - 0014, Pittsburgh, Pennsylvania, United States, 15232
Local Institution - 0012, Seattle, Washington, United States, 98104
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Bristol-Myers Squibb,
Bristol-Myers Squibb, STUDY_DIRECTOR, Bristol-Myers Squibb
2027-12-23